TP53 and acute lymphoblastic leukemia: An Italian cohort study of hypodiploid pediatric ALL patients diagnosed between 2000 and 2019 found that 50% exhibited TP53 variants, with 19 of 20 cases being low-hypodiploid ALL; of these, 13 were pathogenic, and six were classified as variants of unknown significance (VUS) [30,31].